Shiro Katayama
Directeur/Membre du Conseil chez Japan BCG Laboratory KK
Provenance du réseau au premier degré de Shiro Katayama
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Japan BCG Laboratory KK
 Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan.
7
| Private Company | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Shiro Katayama via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|
Statistiques
Internationale
Sectorielle
Opérationnelle
| Director/Board Member | 7 |
| President | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Shin Kaitani | 1 |
| Manabu Sugano | 1 |
| Naoki Nakata | 1 |
| Takahiko Ikegami | 1 |
| Jun Saito | 1 |
| Hoko Yamashita | 1 |
| Tsuguo Sasaki | 1 |
- Bourse
- Insiders
- Shiro Katayama
- Connexions Sociétés
